CHARLOTTE VERMEULEN: Open Payments
NPI 1225469901 · NEW KENSINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$687 in 32 payments from 13 companies in 2025. Trend: 2023 $580 · 2024 $794 · 2025 $687
Food & beverage: $687
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $274 |
| Exact Sciences Corporation | 5 | $122 |
| Alkermes, Inc. | 2 | $49 |
| Dexcom, Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Abbott Laboratories | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Amgen Inc. | 1 | $20 |
Products named: Wegovy, The Cologuard Plus Collection Kit, VIVITROL, Dexcom G6 Transmitter, MOUNJARO, JARDIANCE, CAPLYTA, FREESTYLE LIBRE 3.
Industry payments across PA — which companies pay providers there.
